My Treatment Approach: Chronic Lymphocytic Leukemia

Approaches to planning treatment for patients with newly diagnosed chronic lymphocytic leukemia, as recommended by healthcare professionals from Memorial Sloan Kettering Cancer Center.

EP. 1: CLL: A Heterogeneous Disease

December 6th 2021

Oncology hematology health care professionals from Memorial Sloan Kettering Cancer Center react to the variation in symptoms that patients suspicious of chronic lymphocytic leukemia present with.

EP. 2: CLL: Diagnostic and Prognostic Criteria

December 6th 2021

An overview of tests used to evaluate patients for chronic lymphocytic leukemia and, consequently, inform treatment decisions.

EP. 3: Counseling Patients With Newly Diagnosed CLL

December 6th 2021

Staging criteria used in the diagnosis of chronic lymphocytic leukemia, and recommendations for talking with patients about molecular testing results and goals of therapy.

EP. 4: Approaches to Initiating Therapy for a Patient With CLL and Worsening Symptoms

December 6th 2021

Oncology hematology health care professionals from Memorial Sloan Kettering Cancer Center discuss how to manage a 67-year-old woman with chronic lymphocytic leukemia who develops progressive fatigue and night sweats.

EP. 5: Frontline Therapy for CLL: Chemotherapy-Free Regimens

December 6th 2021

Recommendations for using novel targeted therapies to treat chronic lymphocytic leukemia in the frontline setting.

EP. 6: Targeted Therapies for CLL: Managing Adverse Events

December 6th 2021

Common toxicities associated with novel targeted therapies, such as BTK inhibitors, used to treat chronic lymphocytic leukemia, and recommendations on how to manage with dose adjustments.

EP. 7: Educating Patients About Novel Targeted Therapies for CLL

December 6th 2021

The importance of multidisciplinary care in chronic lymphocytic leukemia and proper patient education on adverse events associated with novel targeted therapies.

EP. 8: Impressions Regarding an Atypical Case of High-Risk CLL

January 17th 2022

Reactions to an atypical diagnosis of high-risk chronic lymphocytic leukemia in a 61-year-old man.

EP. 9: Frontline Targeted Therapy for Newly Diagnosed High-Risk CLL

January 17th 2022

Frontline therapies available to treat newly diagnosed high-risk chronic lymphocytic leukemia, and the rationale for selecting a targeted therapy versus chemoimmunotherapy as initial treatment.

EP. 10: Frontline Anti-CD20 Therapy in CLL

January 24th 2022

The rationale for integrating CD20 monoclonal antibody therapy into the frontline setting of chronic lymphocytic leukemia.